GLP-1 food: start with what people actually eat
Your formula can hit its protein target while the product misses the eating occasion. Here is the question I would put at the top of the brief.
Find the study behind the headline. Check the methods, limitations and implications before you build a product brief around it.
Your formula can hit its protein target while the product misses the eating occasion. Here is the question I would put at the top of the brief.
A steady monthly burn can hide the bills that shorten your runway. Put the commitments and receipts on a calendar.
A polite rejection is not a diagnosis. Seven questions to test against the evidence from your last fundraising conversations.
One bar is measured. The others are modelled. Make the difference visible before an investor asks.
The next generation needs sensory evidence, process capability and commercial discipline. A spending ratio alone cannot tell you who has them.
Platforms are earned through repeatable commercial capability. A defined first ingredient makes that work concrete.
A pilot can produce useful evidence and binding commitments. Map what still separates the trial from the next buying decision.
Check customer demand, unit economics, operations, funding and regulatory planning before the next major commitment.
A funding round does not establish commercial readiness. Examine customer commitments, economics, cash, growth and exit assumptions.
Upstream titre is only part of the production story. Follow recovery, functionality and separation costs through to the saleable ingredient.
Prepare batch records, process limits, contamination investigations and recovery data for an external production trial.
Compare site-specific energy, feedstock, facilities, skills and customer access. A worked calculation shows why location belongs in the cost model.